Gibb H J, Lees P S, Pinsky P F, Rooney B C
U.S. Environmental Protection Agency, Washington, DC 20460, USA.
Am J Ind Med. 2000 Aug;38(2):127-31. doi: 10.1002/1097-0274(200008)38:2<127::aid-ajim2>3.0.co;2-q.
Several reports of workers in chromate production and chromeplating have indicated that exposure to hexavalent chromium is associated with skin and nasal irritation.
A cohort of 2, 357 workers first employed between 1950 and 1974 at a chromate production plant was identified. Clinical findings of irritation were identified by a physician as a result of routine examinations or visits to the medical clinic by members of the cohort. Percentages of the cohort with various clinical findings, the time from hire to occurrence of the first finding, and the mean and median annual hexavalent chromium (measured as CrO(3)) concentration for the job title where the clinical finding first occurred were determined. A proportional hazards model was used to evaluate the relationship between hexavalent chromium exposure and first occurrence of each of the clinical findings.
Nasal irritation and nasal ulceration were the most common clinical findings reported, occurring in more than 60% of the cohort. The average time to first occurrence of these findings was less than 3 months, whereas the time to first occurrence of the other findings ranged from 10 to 22 months. Median exposure to hexavalent chromium at the time of occurrence for most of the findings was about 20 microg/m(3). The proportional hazards model indicated that ulcerated nasal septum, irritated skin, and perforated eardrum were significantly associated with ambient hexavalent chromium exposure; all clinical findings with the exception of conjunctivitis and irritated skin were associated with the calendar year of hire, with the risk being lower as the calendar year of hire became more recent. Annual average ambient hexavalent chromium concentrations generally dropped in the plant over the period of the study.
Workers in the chromate production plant in this study experienced a variety of nasal and skin irritations. Irritated and ulcerated nasal septa, in particular, were quite common clinical findings, occurring in over 60% of the cohort, and they occurred in relatively short periods of time-less than 3 months from date of hire. Annual average concentrations of chromium may not be a good predictor of clinical findings of irritation. Am. J. Ind. Med. 38:127-131, 2000. Published 2000 Wiley-Liss, Inc.
几份关于铬酸盐生产和镀铬工人的报告表明,接触六价铬与皮肤和鼻腔刺激有关。
确定了一组于1950年至1974年间首次受雇于一家铬酸盐生产厂的2357名工人。队列成员因常规检查或到医务室就诊,由医生确定刺激的临床发现。确定了有各种临床发现的队列百分比、从入职到首次发现的时间,以及首次出现临床发现的工作岗位的六价铬(以CrO₃计)年均浓度和中位数浓度。使用比例风险模型评估六价铬暴露与每种临床发现首次出现之间的关系。
鼻腔刺激和鼻溃疡是报告中最常见的临床发现,超过60%的队列出现这些情况。这些发现首次出现的平均时间不到3个月,而其他发现首次出现的时间为10至22个月。大多数发现出现时六价铬的中位数暴露量约为20微克/立方米。比例风险模型表明,鼻中隔溃疡、皮肤刺激和鼓膜穿孔与环境六价铬暴露显著相关;除结膜炎和皮肤刺激外,所有临床发现都与入职年份有关,随着入职年份越近,风险越低。在研究期间,该厂环境六价铬年均浓度总体呈下降趋势。
本研究中铬酸盐生产厂的工人经历了各种鼻腔和皮肤刺激。特别是鼻中隔刺激和溃疡是相当常见的临床发现,超过60%的队列出现这些情况,且在较短时间内出现——从入职日期起不到3个月。铬的年均浓度可能不是刺激临床发现的良好预测指标。《美国工业医学杂志》2000年;38:127 - 131。2000年由威利 - 利斯出版公司出版。